These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Psychoneurosis and drug abuse]. Ravizza L; Bogetto F Minerva Med; 1980 May; 71(19):1363-6. PubMed ID: 7383397 [TBL] [Abstract][Full Text] [Related]
5. [Use and abuse of psychopharmacological agents. Indications and values of preparations in internal medicine diseases]. Lange-Nielsen F Tidsskr Nor Laegeforen; 1969 Sep; 89(17):1353-5. PubMed ID: 5377165 [No Abstract] [Full Text] [Related]
7. The use and abuse of psychic drugs. Witten CL GP; 1966 Aug; 34(2):175-8. PubMed ID: 5946415 [No Abstract] [Full Text] [Related]
8. [Unusual drugs used in the course of drug abuse]. Deniker P; Cottereau MJ; Colonna L; Lôo H Ann Med Psychol (Paris); 1971 Jul; 2(2):245-54. PubMed ID: 5123112 [No Abstract] [Full Text] [Related]
9. [Progress and limitation of psychopharmacological therapy]. Hoff H; Hofmann G Psychiatr Neurol Med Psychol (Leipz); 1967 Dec; 19(12):441-8. PubMed ID: 6082949 [No Abstract] [Full Text] [Related]
10. [Neurobiological research of abuse]. Rosenberg R; Hemmingsen RP Ugeskr Laeger; 1998 Jan; 160(2):153-6. PubMed ID: 9458699 [No Abstract] [Full Text] [Related]
11. The hallucinogenic drugs--their use and abuse. Whitaker LH Med J Aust; 1968 Mar; 1(9):370-1. PubMed ID: 5646708 [No Abstract] [Full Text] [Related]
12. [Drugs and traffic--drug effect on functional capacity and its importance for traffic safety. I]. Dökert B Z Arztl Fortbild (Jena); 1968 Nov; 62(21):1165-71. PubMed ID: 5730217 [No Abstract] [Full Text] [Related]
13. Psychopharmacological agents: tranquillity or morbidity inducers? Iswariah V J Indian Med Assoc; 1968 Apr; 50(8):367-71. PubMed ID: 5665607 [No Abstract] [Full Text] [Related]
14. [Side effects of psychopharmacological agents]. Hippius H Anglo Ger Med Rev; 1965 Nov; 3(1):58-66. PubMed ID: 5855239 [No Abstract] [Full Text] [Related]
15. [The development of modern psychopharmacology. Historical aspects of therapeutic claims and capabilities]. Weber MM Med Ges Gesch; 2000; 19():123-42. PubMed ID: 14674408 [TBL] [Abstract][Full Text] [Related]
16. [Neuropharmacology and psychopharmacology]. Uvnäs B Med Welt; 1969 Apr; 16():942-6. PubMed ID: 5784362 [No Abstract] [Full Text] [Related]
17. Current awareness in human psychopharmacology. Hum Psychopharmacol; 2005 Apr; 20(3):217-24. PubMed ID: 15915562 [No Abstract] [Full Text] [Related]
18. Current awareness in human psychopharmacology. Hum Psychopharmacol; 2004 Jul; 19(5):361-8. PubMed ID: 15338577 [No Abstract] [Full Text] [Related]
19. Intersection of minority health, health disparities, and social determinants of health with psychopharmacology and substance use. Lopez-Vergara HI; Zapolski TCB; Leventhal AM Exp Clin Psychopharmacol; 2021 Oct; 29(5):427-428. PubMed ID: 34636584 [TBL] [Abstract][Full Text] [Related]